FDA OKs emergency use of COVID-19 test with saliva specimens

The FDA has signed off on the emergency use of a laboratory-developed test (LDT) at Rutgers Clinical Genomics Laboratory that detects the presence of the SARS-CoV-2 virus in saliva, its first nod for a molecular test of this type.

Patients can self-collect specimens at home using Salt Lake City, UT-based Spectrum Solutions LLC’s Spectrum DNA SDNA-1000 Saliva Collection Device.

Selected tickers: Abbott (ABT +0.4%), Roche (OTCQX:RHHBY +0.7%), Thermo Fisher Scientific (TMO -1.2%), LabCorp (LH +3.3%), Quest Diagnostics (DGX +3.7%), Co-Diagnostics (CODX +3.1%), Becton, Dickinson (BDX +0.3%)

https://seekingalpha.com/news/3572277-fda-oks-emergency-use-of-covidminus-19-test-saliva-specimens